New hope for pancreatic cancer? trial tests drug combo
NCT ID NCT03417921
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study tested a new drug called ABTL0812 combined with standard chemotherapy for people with advanced pancreatic cancer that has spread. The goal was to see if the combination is safe and works better than chemo alone. The trial was suspended, so results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Marc Cortal
Barcelona, 08190, Spain
Conditions
Explore the condition pages connected to this study.